Evidence-based use of adjunctive therapies to ventilation

Thomas E Wiswell1, Win Tin, Kirsten Ohler

  • 1Center for Neonatal Care, Florida Hospital Orlando, 2718 North Orange Avenue, Suite B, Orlando, FL 32804, USA. thomas_wiswell@yahoo.com

Insights

This review examines adjunctive therapies for common neonatal lung diseases, including respiratory distress syndrome and bronchopulmonary dysplasia. It evaluates the evidence supporting or refuting their use in newborn intensive care units.

Area of Science:

  • Neonatology
  • Pulmonology
  • Pediatric critical care

Background:

  • Respiratory distress is a leading cause for neonatal intensive care unit admissions.
  • Neonatal pulmonary disorders significantly impact infant health outcomes.
  • Therapeutic strategies for neonates with lung disease have evolved substantially.

Purpose of the Study:

  • To review and synthesize the evidence for adjunctive therapies in neonatal lung diseases.
  • To assess the efficacy and safety of various treatment modalities.
  • To provide an evidence-based overview for clinicians managing these conditions.

Main Methods:

  • Systematic review of existing literature.
  • Analysis of clinical trials and observational studies.
  • Evidence appraisal for specific neonatal pulmonary conditions.

Main Results:

  • Evidence varies significantly across different adjunctive therapies and neonatal lung conditions.
  • Some therapies show promise in mitigating disease course, while others lack robust support.
  • Specific recommendations are discussed for respiratory distress syndrome, bronchopulmonary dysplasia, and other disorders.

Conclusions:

  • Adjunctive therapies play a role in managing neonatal lung disease, but their application requires careful consideration of evidence.
  • Further research is needed to establish definitive guidelines for certain treatments.
  • Optimizing treatment strategies can improve outcomes for neonates with respiratory disorders.

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation (NIPPV)
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Mechanical Ventilation I: Indication and Settings01:29

Mechanical Ventilation I: Indication and Settings

Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...